Skip to content
OpenCapital
Get started

Prestige Consumer Healthcare PBH Cash & Equivalents

Cash & Equivalents at other companies

Procter & Gamble logo
Procter & GamblePG
$12.31B+35.0%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$21.69B-43.6%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$1.31B+13.4%
Cencora logo
CencoraCOR
$2.18B+10.0%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$666.7M+90.7%
Cardinal Health logo
Cardinal HealthCAH
$3.94B+18.4%

Other financials

Income statement

See full
Revenue$281.6M-5.0%
Gross profit$146.3M-13.9%
Operating income$75.5M-14.6%
Net income$53.9M+7.6%
EPS (diluted)$1.13+11.9%

Balance sheet

See full
Total debt$1.0B-0.2%
Total equity$1.9B+2.9%
Total assets$3.5B+2.7%

Cash flow

See full
Operating cash flow$42.8M-30.7%
CapEx$5.2M+49.8%
Free cash flow$37.6M-35.5%

Valuation

See full
Market cap$2.18B-34.1%
Enterprise value$3.16B-27.3%
P/E11.5×-4.0×
P/S2×-0.9×

Profitability

See full
Gross margin54.7%-1.1pp
Operating margin28.4%-1.2pp
Net margin17.5%-1.4pp
FCF margin22.6%+1.3pp

Returns & leverage

See full
Return on equity10.2%-2.1pp
Debt / equity0.6×0.0×
Current ratio3.6×-0.6×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Prestige Consumer Healthcare’s 10-K, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prestige Consumer Healthcare's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prestige Consumer Healthcare's cash & equivalents?
Prestige Consumer Healthcare (PBH) reported cash & equivalents of $63.87M in Q1 2026.
How has Prestige Consumer Healthcare's cash & equivalents changed year-over-year?
Prestige Consumer Healthcare's cash & equivalents decreased by 34.8% year-over-year, from $97.88M to $63.87M.
What is the long-term trend for Prestige Consumer Healthcare's cash & equivalents?
Over 5 years (2021 to 2026), Prestige Consumer Healthcare's cash & equivalents has grown at a 14.6% compound annual growth rate (CAGR), from $32.3M to $63.87M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.